Iterative Polyketide Synthase Function, Structure and Pathways
Iterative Polyketide Synthase Function, Structure and Pathways
批准号:
10541826
负责人:
CRAIG ARTHUR TOWNSEND
金额:
$45.83万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1978
资助国家:
美国
项目状态:
已结题
起止时间:
1978-02-01 至 2024-12-31
关键词:
3-hydroxybutanalAcyl Carrier ProteinAgricultureAnabolismAnimalsAnthraquinonesAntibodiesAntibody-drug conjugatesArchitectureBehaviorBiochemicalBiosynthetic ProteinsCRISPR/Cas technologyCarboxylic AcidsCatalysisCatalytic DomainClientClustered Regularly Interspaced Short Palindromic RepeatsCollaborationsCryoelectron MicroscopyCyclizationDNADehydrationDynemicinEnvironmental CarcinogensEnzymesEventFamilyFatty-acid synthaseFoodFood SupplyGene ClusterGene DeletionGenesGoalsHealthHigher Order Chromatin StructureHumanIndividualInvestigationKetonesLaboratoriesLaccaseLeadLengthMedicineMethodsMethylationMolecular ConformationMolecular MachinesMutationNatural ProductsPathogenicityPathway interactionsPharmacologic SubstancePhotosensitizing AgentsPlantsPolymersProductionProtein FamilyReactive Oxygen SpeciesRoentgen RaysRoleScientistStructureSystemTechnologyTestingToxic Environmental SubstancesToxinTransferaseUnited States Department of AgricultureVisualizationX-Ray Crystallographycancer therapycercosporincombatcostcrosslinkfasciclinfascinategraspinsightpathogenplant poisonpolyketide synthasepolyketidespolymerizationprotein structuresuccesswelfare
中文摘要
多酮类化合物对人类健康和福利的重要性已得到主要制药公司的认可
英文摘要
The importance of polyketides to human health and welfare is recognized both by major pharmaceuticals
and important environmental carcinogens and mammalian toxins, as well as phytotoxins that impose heavy
costs on agriculture and endanger the food supply. In three major Aims, we propose to undertake fundamental
biochemical and structural studies of representatives from two major families of iterative polyketide synthases,
which exemplify some of the most sophisticated catalytic systems known and pose many unanswered questions
about how the coordinated function of their individual catalytic domains is achieved. Unequivocal
determination of the programmed product of the enediyne highly-reducing (HR)-PKSs will be extended to
investigation of how this simple, shared intermediate is converted to the enediyne and anthraquinone “halves”
of dynemicin A and other enediyne architectures.
With advances in antibody technology, conjugates of enediyne natural products are coming again as
valuable anti-cancer therapies. The biosynthesis of these structurally intriguing DNA-cleaving molecules
remains one of the principal unsolved problems in natural product biosynthesis. Application of precise
CRISPR/Cas9 gene deletions in the dynemicin A pathway has brought exciting experimental advances to isolate
and characterize the first post-PKS intermediates in any enediyne biosynthetic pathway. Additional mutational
studies will be carried out, the structures of other possible intermediates will be elucidated and a strategy of
paired CRISPR mutations will be developed to finally crack how these fascinating structures are made.
Having first detected and functionally characterized “starter-unit acyl transferase” (SAT) domains and
“product template” (PT) domains in NR-PKSs, we are now poised to build from static structures of individual
domains, stepwise to tridomains and tetradomains to, finally, full-length structures. In this Aim collaboration
with the laboratory of Timm Maier (Biozentrum, Univ. of Basel) will couple biochemical studies, ACP–client
crosslinking, x-ray crystallography and cryo-electron microscopy to achieve the next level of understanding to
visualize how these separate components integrate their actions into fully functional molecular machines.
Cercospora sp. cause immense damage to a range of vital food crops through the production of
cercosporin, a diabolically efficient photosensitizer of reactive oxygen species and pathogenic to plants (and
animals). The mostly unexplored biosynthesis of this perylenequinone will be undertaken and previous
biogenetic proposals will be corrected. The roles of a laccase/fasciclin-family protein and other newly discovered
biosynthetic proteins encoded in an expanded biosynthetic gene cluster will be studied in collaboration with
scientists at the USDA with the added goal to find “green” ways to combat toxin production by this pathogen.
!
期刊论文(27)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1021/ol503078h
发表时间:
2014-12-19
期刊:
ORGANIC LETTERS
影响因子:
5.2
作者:
[Outlaw, Victor K., Townsend, Craig A.]
通讯作者:
Townsend, Craig A.
Sterigmatocystin production on complex and defined substrates.
在复杂且确定的底物上生产杂色曲霉素。
DOI:
10.1007/bf00443827
发表时间:
1989
期刊:
Mycopathologia
影响因子:
5.5
作者:
[Bennett,JW, Henderberg,A, Grossman,K]
通讯作者:
Grossman,K
DOI:
10.1021/cr300169a
发表时间:
2013-03-13
期刊:
CHEMICAL REVIEWS
影响因子:
62.1
作者:
[Labonte, Jason W., Townsend, Craig A.]
通讯作者:
Townsend, Craig A.
DOI:
10.1002/anie.201206462
发表时间:
2012-11-05
期刊:
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
影响因子:
16.6
作者:
[Belecki, Katherine, Townsend, Craig A.]
通讯作者:
Townsend, Craig A.
DOI:
10.1039/c6ra10605f
发表时间:
2016-07-08
期刊:
RSC advances
影响因子:
3.9
作者:
[Outlaw VK, Zhou J, Bragg AE, Townsend CA]
通讯作者:
Townsend CA
共 16 条
Biosynthesis of Beta Lactam Antibiotics
-
批准号:10295587
-
项目类别:
-
资助金额:$56.09万
-
财政年份:2016
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
Biosynthesis of Beta Lactam Antibiotics
-
批准号:10406371
-
项目类别:
-
资助金额:$62.97万
-
财政年份:2016
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
Biosynthesis of Beta Lactam Antibiotics
-
批准号:10601097
-
项目类别:
-
资助金额:$61.94万
-
财政年份:2016
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
400 MHZ NMR SPECTROMETER FOR SHARED USE: CHEMISTRY
-
批准号:6973212
-
项目类别:
-
资助金额:$36.37万
-
财政年份:2004
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
400 MHz NMR Spectrometer for Shared Use
-
批准号:6735938
-
项目类别:
-
资助金额:$36.37万
-
财政年份:2004
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
FINNIGAN LCQ ELECTROSPRAY MASS SPECTROMETER
-
批准号:6052089
-
项目类别:
-
资助金额:$19.83万
-
财政年份:2000
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
DIYNENE ANTIBIOTICS AND THEIR DNA CLEAVAGE CHEMISTRY
-
批准号:2095928
-
项目类别:
-
资助金额:$16.92万
-
财政年份:1991
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
DIYNENE ANTIBIOTICS AND THEIR DNA CLEAVAGE CHEMISTRY
-
批准号:2700458
-
项目类别:
-
资助金额:$24.78万
-
财政年份:1991
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
500 MHZ NMR INSTRUMENTATION FOR SHARED USE
-
批准号:3521167
-
项目类别:
-
资助金额:$40.0万
-
财政年份:1991
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
DIYNENE ANTIBIOTICS AND THEIR DNA CLEAVAGE CHEMISTRY
-
批准号:2414220
-
项目类别:
-
资助金额:$17.04万
-
财政年份:1991
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
DIYNENE ANTIBIOTICS AND THEIR DNA CLEAVAGE CHEMISTRY
-
批准号:3198981
-
项目类别:
-
资助金额:$16.86万
-
财政年份:1991
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
DIYNENE ANTIBIOTICS AND THEIR DNA CLEAVAGE CHEMISTRY
-
批准号:3198979
-
项目类别:
-
资助金额:$17.56万
-
财政年份:1991
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
DIYNENE ANTIBIOTICS AND THEIR DNA CLEAVAGE CHEMISTRY
-
批准号:3198980
-
项目类别:
-
资助金额:$16.75万
-
财政年份:1991
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
DIYNENE ANTIBIOTICS AND THEIR DNA CLEAVAGE CHEMISTRY
-
批准号:2095929
-
项目类别:
-
资助金额:$18.72万
-
财政年份:1991
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
DIYNENE ANTIBIOTICS AND THEIR DNA CLEAVAGE CHEMISTRY
-
批准号:2095930
-
项目类别:
-
资助金额:$26.38万
-
财政年份:1991
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
300 MHZ NMR INSTRUMENTATION FOR SHARED USE
-
批准号:3520276
-
项目类别:
-
资助金额:$27.5万
-
财政年份:1989
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
KRATOS MS-80 MASS SPECTROMETER
-
批准号:3519110
-
项目类别:
-
资助金额:$30.0万
-
财政年份:1985
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
BIOSYNTHESIS OF AFLATOXIN
-
批准号:2153065
-
项目类别:
-
资助金额:$23.24万
-
财政年份:1978
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
BIOSYNTHESIS OF AFLATOXIN
-
批准号:2153066
-
项目类别:
-
资助金额:$24.25万
-
财政年份:1978
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
BIOSYNTHESIS OF AFLATOXIN
-
批准号:2153064
-
项目类别:
-
资助金额:$22.48万
-
财政年份:1978
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
海外基金